Director, Oncology Public Affairs
AbbVie
July 02, 2026
Remote friendly (Mettawa, IL)
United States
$160,500 - $305,000 USD yearly
Patient Advocacy
Purpose
The Director of Oncology Public Affairs leads the communications strategy and execution for Phase 3, on-market, and late-stage oncology therapies in multiple myeloma, lung, and colorectal cancer. Reports to the Head, Oncology Public Affairs. Based in Lake County, Chicago.
Key Responsibilities
- Drive strategic execution of integrated communications programs for oncology assets in partnership with cross-functional colleagues (Marketing, Medical Affairs, Government Affairs, etc.).
- Develop and execute communications strategies that advance commercial priorities for on-market therapies, including campaigns and disease state education to enhance reputation with external stakeholders.
- Anticipate and prepare for the launch of oncology pipeline assets in key global markets to support access to innovative therapies.
- Partner with external stakeholders, including co-commercialization partners, public affairs agency partners, and oncology advocacy organizations.
Qualifications
- Minimum 10 years of public affairs experience in the pharmaceutical/biotech industry, with significant experience leading oncology communications in the U.S. Experience leading U.S. FDA launches and working with other regulatory bodies preferred.
- Expertise in developing and executing insight-driven, strategic, measurable external public affairs programs.
- Ability to work effectively across cross-functional and internal/external stakeholders.
- Enterprise mindset and ability to connect internal and external stakeholders.
- Strong business acumen and storytelling capabilities.
- Strong communication planning/execution and process management; strong interpersonal skills to build rapport and credibility with leaders, experts, patients, and advocates.
- Expertise in media relations, corporate reputation, and issues management in oncology.
- Knowledge of regulations governing communications for publicly traded biopharmaceutical companies.
Benefits (as stated)
- Paid time off; medical/dental/vision insurance; 401(k); eligible for long-term incentive programs.
The Director of Oncology Public Affairs leads the communications strategy and execution for Phase 3, on-market, and late-stage oncology therapies in multiple myeloma, lung, and colorectal cancer. Reports to the Head, Oncology Public Affairs. Based in Lake County, Chicago.
Key Responsibilities
- Drive strategic execution of integrated communications programs for oncology assets in partnership with cross-functional colleagues (Marketing, Medical Affairs, Government Affairs, etc.).
- Develop and execute communications strategies that advance commercial priorities for on-market therapies, including campaigns and disease state education to enhance reputation with external stakeholders.
- Anticipate and prepare for the launch of oncology pipeline assets in key global markets to support access to innovative therapies.
- Partner with external stakeholders, including co-commercialization partners, public affairs agency partners, and oncology advocacy organizations.
Qualifications
- Minimum 10 years of public affairs experience in the pharmaceutical/biotech industry, with significant experience leading oncology communications in the U.S. Experience leading U.S. FDA launches and working with other regulatory bodies preferred.
- Expertise in developing and executing insight-driven, strategic, measurable external public affairs programs.
- Ability to work effectively across cross-functional and internal/external stakeholders.
- Enterprise mindset and ability to connect internal and external stakeholders.
- Strong business acumen and storytelling capabilities.
- Strong communication planning/execution and process management; strong interpersonal skills to build rapport and credibility with leaders, experts, patients, and advocates.
- Expertise in media relations, corporate reputation, and issues management in oncology.
- Knowledge of regulations governing communications for publicly traded biopharmaceutical companies.
Benefits (as stated)
- Paid time off; medical/dental/vision insurance; 401(k); eligible for long-term incentive programs.